Bristol-Myers Squibb in settlement over Australia breast implants:
This article was originally published in Clinica
Bristol-Myers Squibb has reached an out-of-court settlement with a group of 87 women in Australia over faulty breast implants. Terms of the settlement were not disclosed. Lawyer Peter Cashman said the women's complaints ranged from minor cosmetic problems to major illnesses. A further 1,300 women are suing the Australian arm of US company Dow Corning over faulty breast implants. This case is due to return to court in October 2002.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.